Skip to main content

Advertisement

Table 2 Frequency of group 1, 2A, 2B, 3 and unclassified HPV genotypes among NILM, low grade SIL and high grade SIL

From: Prevalence of “unclassified” HPV genotypes among women with abnormal cytology

Species HPV genotypea All samples
n = 337 (%)
NILM
n = 96 (%)
LSIL
n = 226 (%)
HSIL
n = 15 (%)
  HPV Negative 107 (31.8) 61 (63.5) 45 (20.0) 1 (6.7)
  HPV Positive 230 (68.3) 35 (36.5) 181 (80.0) 14 (93.3)
  Group 1
A9 HPV16 40 (11.9) 5 (5.2) 30 (13.3) 5 (33.3)
A7 HPV18 13 (3.9) 2 (2.1) 10 (4.4) 1 (6.7)
A9 HPV31 18 (5.3) 0 17 (7.5) 1 (6.7)
A9 HPV33 11 (3.3) 1 (1.0) 9 (3.9) 1 (6.7)
A9 HPV35 2 (0.6) 0 1 (0.4) 1 (6.7)
A7 HPV39 7 (2.1) 1 (1.0) 5 (2.2) 1 (6.7)
A7 HPV45 7 (2.1) 0 7 (3.1) 0
A5 HPV51 6 (1.8) 0 5 (2.2) 1 (6.7)
A9 HPV52 10 (3.0) 4 (4.2) 6 (2.7) 0
A6 HPV56 10 (3.0) 3 (3.1) 5 (2.2) 2 (13.3)
A9 HPV58 8 (2.4) 3 (3.1) 5 (2.2) 0
A7 HPV59 7 (2.1) 2 (2.1) 5 (2.2) 0
  Total Group 1 139 (41.3) 21 (21.9) 105 (46.5) 13 (86.7)
  Group 2A
A7 HPV68 3 (0.9) 1 (1.0) 2 (0.8) 0
  Group 2B
A6 HPV53 22 (6.5) 2 (2.1) 19 (8.4) 1 (7.1)
A6 HPV66 21 (6.2) 1 (1.0) 17 (7.5) 3 (21.4)
A9 HPV67 3 (0.9) 0 3 (1.3) 0
A7 HPV70 5 (1.5) 0 5 (2.2) 0
A11 HPV73 2 0.6) 0 2 (0.9) 0
A5 HPV82 2 (0.6) 1 (1.0) 1 (0.4) 0
A11 HPV34 1 (0.3) 0 1 (0.4) 0
A7 HPV85 1 (0.3) 0 1 (0.4) 0
  Total Group 2B 57 (16.9) 4 (4.2) 49 (21.7) 4 (26.7)
  Group 3
A10 HPV6 8 (2.4) 2 (2.1) 6 (2.7) 0
A10 HPV11 1 (0.3) 0 1 (0.4) 0
  Total Group 3 9 (2.7) 2 (2.1) 7 (3.1) 0
  Unclassified
A3 HPV81 7 (2.1) 1 (1.0) 6 (2.7) 0
A1 HPV42 5 (1.5) 0 5 (2.2) 0
A3 HPV62 6 (1.8) 1 (1.0) 5 (2.2) 0
A10 HPV55 4 (1.2) 1 (1.0) 3 (1.3) 0
A3 HPV89 4 (1.2) 3 (3.1) 1 (0.4) 0
A8 HPV91 4 (1.2) 0 4 (1.8) 0
A13 HPV54 3 (0.9) 0 3 (1.3) 0
A14 HPV90 3 (0.9) 1 (1.0) 2 (0.9) 0
A3 HPV84 2 (0.6) 1 (1.0) 1 (0.4) 0
A3 HPV61 1 (0.3) 0 1 (0.4) 0
A3 HPV83 1 (0.3) 0 1 (0.4) 0
B1 HPV12 1 (0.3) 0 1 (0.4) 0
  Total Unclassified 41 (12.2) 8 (8.3) 33 (14.6) 0
  1. aType-specific prevalence includes HPVs in single or multiple infections